The study drug is SHED-CM manufactured by U-Factor

BIOLOGICAL2 trials

Sponsors

Hitonowa Medical

Conditions

Amyotrophic Lateral Sclerosis

Early Phase 1

Safety and Efficacy of Intravenous Administration of SHED-CM for ALS

Active, not recruitingNCT06889857

Hitonowa MedicalAmyotrophic Lateral Sclerosis

Start: 2024-04-05End: 2026-12-31Target: 10Updated: 2025-09-15

Unknown Phase

Retrospective Study on the Safety and Therapeutic/Improvement Effects of Intravenous Administration of SHED-CM for ALS (SHED-CAH2023)

CompletedNCT06608719

Hitonowa MedicalAmyotrophic Lateral Sclerosis

Start: 2023-12-25End: 2024-07-01Updated: 2024-09-23